European Journal Of Haematology

European Journal Of Haematology

欧洲血液学杂志

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《European Journal Of Haematology》是由Wiley-Blackwell Publishing Ltd出版社于1987年创办的英文国际期刊(ISSN: 0902-4441,E-ISSN: 1600-0609),该期刊长期致力于血液学领域的创新研究,主要研究方向为医学-血液学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.1534...%),以发表血液学领域等方向的原创性研究为核心(研究类文章占比82.46%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在211篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

European Journal Of Haematology审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约211篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 211 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
HEMATOLOGY 血液学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
HEMATOLOGY 血液学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q2 48 / 97

51%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEMATOLOGY SCIE Q2 43 / 97

56.19%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.5 SJR:0.944 SNIP:0.996
学科类别 分区 排名 百分位
大类:Medicine 小类:Hematology Q2 45 / 137

67%

期刊发文

  • High expression of AP2M1 correlates with worse prognosis by regulating immune microenvironment and drug resistance to R-CHOP in diffuse large B cell lymphoma

    Author: Liu, Xindi; Zhao, Xiaoli; Yang, Jing; Wang, Henan; Piao, Yingshi; Wang, Liang

    Journal: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; Vol. 110, Issue 2, pp. 198-208. DOI: 10.1111/ejh.13895

  • Long-term outcomes of aplastic anemia with cytogenetic abnormalities at diagnosis

    Author: Li, Jianping; Liu, Xu; Zhao, Xin; Yang, Wenrui; Zhang, Li; Jing, Liping; Zhou, Kang; Ye, Lei; Li, Yuan; Li, Yang; Peng, Guangxin; Song, Lin; Fan, Huihui; Hu, Xiangrong; Li, Xiaoxia; Zhang, Fengkui

    Journal: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; Vol. 110, Issue 4, pp. 379-385. DOI: 10.1111/ejh.13913

  • Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia

    Author: Chen, Yixiang; Shao, Xiaoya; Yang, Haiping; Ren, Leiying; Cui, Ying; Zhang, Wenlu; Macip, Salvador; Meng, Xueqiong

    Journal: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; Vol. 110, Issue 4, pp. 435-443. DOI: 10.1111/ejh.13921

  • Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation

    Author: Zheng, Xinhui; Zhang, Haixiao; Guo, Wenwen; Cao, YiGeng; Liu, Xin; Zhai, WeiHua; Zhang, Xiaoyu; Wang, Fengjiao; Wei, JiaLin; Yang, DongLin; Huang, Yong; Pang, AiMing; Feng, SiZhou; Jiang, ErLie; Han, MingZhe

    Journal: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; Vol. 110, Issue 5, pp. 527-533. DOI: 10.1111/ejh.13925

  • TP53 signal pathway confers potential therapy target in acute myeloid leukemia

    Author: Zhu, Gelan; Cai, Jiayi; Zhong, Hua

    Journal: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; Vol. 110, Issue 5, pp. 480-489. DOI: 10.1111/ejh.13934

  • RNA-binding protein PUM2 promotes T-cell acute lymphoblastic leukemia via competitively binding to RBM5 3 ' UTR with miR-28-5p

    Author: Bai, Taomin; Liu, Na

    Journal: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; Vol. 110, Issue 5, pp. 498-509. DOI: 10.1111/ejh.13914

  • Clinical, biological, and outcome features of P2RY8-CRLF2 and CRLF2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol

    Author: Wang, Ying; Li, Jun; Xue, Tian-Lin; Tian, Shuo; Yue, Zhi-Xia; Liu, Shu-Guang; Gao, Chao

    Journal: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; Vol. 110, Issue 6, pp. 669-679. DOI: 10.1111/ejh.13948

  • Superiority of ibrutinib plus bendamustine and rituximab in newly diagnosed patients with mantle-cell lymphoma ineligible for intensive therapy: A network meta-analysis

    Author: Sheng, Zhixin; Wang, Lida

    Journal: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; Vol. 110, Issue 6, pp. 602-607. DOI: 10.1111/ejh.13953